Robert Kuhn - AptarGroup President
| ATR Stock | USD 140.01 0.27 0.19% |
President
Mr. Robert W. Kuhn is a Chief Financial Officer, Executive Vice President, Secretary of the Company. Mr. Kuhn was Executive Vice President and Chief Financial Officer since September 2008. Mr. Kuhn was Secretary since June 2011. Prior to this, Mr. Kuhn was Vice President Financial Reporting from 2000 to 2008. since 2021.
| Age | 62 |
| Tenure | 3 years |
| Address | 265 Exchange Drive, Crystal Lake, IL, United States, 60014 |
| Phone | 815 477 0424 |
| Web | https://www.aptar.com |
AptarGroup Management Efficiency
The company has Return on Asset of 0.0651 % which means that on every $100 spent on assets, it made $0.0651 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1295 %, implying that it generated $0.1295 on every 100 dollars invested. AptarGroup's management efficiency ratios could be used to measure how well AptarGroup manages its routine affairs as well as how well it operates its assets and liabilities. At this time, AptarGroup's Return On Capital Employed is relatively stable compared to the past year. As of 04/25/2024, Return On Assets is likely to grow to 0.08, while Return On Tangible Assets are likely to drop 0.06. At this time, AptarGroup's Total Assets are relatively stable compared to the past year. As of 04/25/2024, Non Current Assets Total is likely to grow to about 3 B, while Total Current Assets are likely to drop slightly above 919.2 M.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| William Burke | Haemonetics | 52 | |
| Robert Simpson | AngioDynamics | 45 | |
| Brent Boucher | AngioDynamics | 50 | |
| Joseph Wright | Merit Medical Systems | 54 | |
| Tom McCall | ICU Medical | 60 | |
| James Darecca | Haemonetics | 50 | |
| Thomas Powell | Teleflex Incorporated | 62 | |
| Jake Newman | Teleflex Incorporated | N/A | |
| Daniel McBride | The Cooper Companies | 56 | |
| Jeffrey Kappler | Envista Holdings Corp | 41 | |
| Karen Boylan | Teleflex Incorporated | 47 | |
| Cameron Hicks | Teleflex Incorporated | 59 | |
| Virginia Sanzone | ICU Medical | 49 | |
| David Wilson | Haemonetics | N/A | |
| Barbara Kucharczyk | AngioDynamics | 43 | |
| Michelle Basil | Haemonetics | 52 | |
| Agostino Ricupati | The Cooper Companies | 57 | |
| Holly Sheffield | The Cooper Companies | 53 | |
| Thomas McCurdy | Haemonetics | N/A | |
| Lisa Kudlacz | Teleflex Incorporated | N/A | |
| Seyed Mirsaid | Haemonetics | 56 | |
Management Performance
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0651 |
AptarGroup Leadership Team
Elected by the shareholders, the AptarGroup's board of directors comprises two types of representatives: AptarGroup inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AptarGroup. The board's role is to monitor AptarGroup's management team and ensure that shareholders' interests are well served. AptarGroup's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AptarGroup's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Shiela Vinczeller, Chief Human Resource Officer | ||
| B Owens, Independent Director | ||
| Marry Skafidas, Senior Communications | ||
| Jenwei Wu, Independent Director | ||
| Ursula SaintLeger, Vice President - Human Resources | ||
| Stephan Tanda, President, Chief Executive Officer, Director | ||
| Andreas Kramvis, Independent Director | ||
| Ralf Wunderlich, Independent Director | ||
| Robert Kuhn, Chief Financial Officer, Executive Vice President, Secretary | ||
| Salim Haffar, President of Aptar Pharma | ||
| Maritza Montiel, Independent Director | ||
| Marc Prieur, President - Aptar Food + Beverage | ||
| Giovanna Monnas, Independent Director | ||
| Eldon Schaffer, Executive Vice President - Strategic Projects and Commercial Excellence | ||
| King Harris, Independent Chairman of the Board and Presidentiding Director | ||
| Hedi Tlili, President Beverage | ||
| Isabel MareySemper, Independent Director | ||
| Matt DellaMaria, Vice President - Investor Relations | ||
| Candace Matthews, Independent Director | ||
| George Fotiades, Independent Non-Executive Chairman of the Board | ||
| Gael Touya, President Aptar Food and Beverage | ||
| Heidi Tlili, President - Aptar Food + Beverage | ||
| Craig Owens, Director | ||
| Marc Prieurvia, President - Aptar Food + Beverage | ||
| Xiangwei Gong, President - Aptar Asia | ||
| Stephen Hagge, CEO and President Director and Member of Executive Committee | ||
| Jesse Wu, Independent Director | ||
| Joanne Smith, Independent Director | ||
| Alain Chevassus, Independent Director | ||
| Kimberly Chainey, Executive Vice President Global General Counsel, Secretary | ||
| Matthew DellaMaria, VP Communications | ||
| Peter Pfeiffer, Director and Member of Executive Committee |
AptarGroup Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is AptarGroup a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0651 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.13 % | ||||
| Current Valuation | 10.25 B | ||||
| Shares Outstanding | 66.17 M | ||||
| Shares Owned By Insiders | 0.50 % | ||||
| Shares Owned By Institutions | 91.87 % | ||||
| Number Of Shares Shorted | 331.09 K | ||||
| Price To Earning | 28.95 X |
Pair Trading with AptarGroup
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AptarGroup position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AptarGroup will appreciate offsetting losses from the drop in the long position's value.Moving together with AptarGroup Stock
| 0.78 | ALC | Alcon AG Financial Report 14th of May 2024 | PairCorr |
Moving against AptarGroup Stock
| 0.67 | EKSO | Ekso Bionics Holdings Earnings Call This Week | PairCorr |
| 0.67 | EMBC | Embecta Corp Financial Report 10th of May 2024 | PairCorr |
| 0.52 | XRAY | Dentsply Sirona Earnings Call This Week | PairCorr |
| 0.47 | HBIO | Harvard Bioscience | PairCorr |
The ability to find closely correlated positions to AptarGroup could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AptarGroup when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AptarGroup - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AptarGroup to buy it.
The correlation of AptarGroup is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AptarGroup moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AptarGroup moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AptarGroup can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AptarGroup. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in AptarGroup Stock, please use our How to Invest in AptarGroup guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for AptarGroup Stock analysis
When running AptarGroup's price analysis, check to measure AptarGroup's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AptarGroup is operating at the current time. Most of AptarGroup's value examination focuses on studying past and present price action to predict the probability of AptarGroup's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AptarGroup's price. Additionally, you may evaluate how the addition of AptarGroup to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |
Is AptarGroup's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AptarGroup. If investors know AptarGroup will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AptarGroup listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.044 | Dividend Share 1.58 | Earnings Share 4.26 | Revenue Per Share 53.149 | Quarterly Revenue Growth 0.053 |
The market value of AptarGroup is measured differently than its book value, which is the value of AptarGroup that is recorded on the company's balance sheet. Investors also form their own opinion of AptarGroup's value that differs from its market value or its book value, called intrinsic value, which is AptarGroup's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AptarGroup's market value can be influenced by many factors that don't directly affect AptarGroup's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AptarGroup's value and its price as these two are different measures arrived at by different means. Investors typically determine if AptarGroup is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AptarGroup's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.